MassDevice.com +5 | The top 5 medtech stories for April 11, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Stimwave wins Australian regulatory nod for Freedom SCS Stimwave Technologies said late last week it won approval from the Australian Therapeutic Goods Administration for its Freedom spinal cord stimulation system, and launched the device in the country. The Ft. Lauderdale-based company touts the Freedom SCS as the world’s 1st wireless, fully programmable neuromodulation device intended for treating chronic, intractable pain of the back or legs. Read more 4. Adgero touts data for photodynamic drug-device combo Adgero Biopharmaceuticals touted positive clinical data from studies of its late-stage photodynamic therapy platform for the treatment of cutaneous oncology indications, including unresectable metastatic breast cancer. The Princeton, N.J.-based company’s REM-001 therapy consists of a laser light source, a light delivery device and a photosensitizer drug. Read more 3. Silicon Valley Bank puts up $25m credit line for Organogenesis Organogenesis said that it entered into a revolving line of credit agreement with Silicon Valley Bank to provide $25 million in new capital...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news